Clinical Research Directory
Browse clinical research sites, groups, and studies.
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
Sponsor: Tulane University
Summary
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2021-07-12
Completion Date
2026-07
Last Updated
2026-03-04
Healthy Volunteers
Yes
Interventions
Delayed enhancement magnetic resonance imaging (DE-MRI)
The patient will be injected with late gadolinium enhancement (0.01 mmol/kg standard dosage), which is a contrast agent used in clinical practice in MRI imaging studies. The contrast agent is used to enhance specific regions/tissues on MRI and, in this study, will allow the investigators to identify fibrotic tissue within the heart. The patient then undergoes the MRI sequence, which lasts approximately 20-25 minutes. Images will be reviewed for quality by trained technicians. This will be repeated after 6 months.
Locations (3)
East Jefferson General Hospital
New Orleans, Louisiana, United States
University Medical Center
New Orleans, Louisiana, United States
Tulane Doctors - Speciality Care - Napoleon
New Orleans, Louisiana, United States